Pfizer announcement and AstraZeneca statement
- Details
- Category: Financial
Pfizer wishes to enter into discussions with AstraZeneca regarding a potential combination of the two companies and is "disappointed at the lack of engagement by the AstraZeneca Board". The Board of AstraZeneca notes the announcement made by Pfizer and states that the "announcement contains no new proposal nor substantive new information."
More than 19,000 Novartis associates worldwide volunteer for local causes on Community Partnership Day
- Details
- Category: Novartis

Pfizer reports first-quarter 2014 results
- Details
- Category: Pfizer

AstraZeneca Board rejects Pfizer proposal
- Details
- Category: AstraZeneca

Pfizer sends letter to Rt Hon David Cameron MP regarding commitments if proposed combination with AstraZeneca is completed
- Details
- Category: Pfizer

Bayer: Very successful start to 2014
- Details
- Category: Bayer

Pfizer Confirms prior discussions with AstraZeneca
- Details
- Category: Pfizer

More Pharma News ...
- Novartis delivered solid sales and profit growth in the first quarter of 2014
- Bristol-Myers Squibb ranks first on 2014 Best Corporate Citizens List
- Novartis announces portfolio transformation
- Abbott reports first-quarter 2014 results
- Roche with good start in 2014
- Abbott completes enrollment of Absorb™ randomized clinical trials in the United States, Japan and China
- Novartis and Malaria No More provide two million antimalarial treatments to children in Zambia